Lista de obras - Catherine A. Byrnes - Dominio Público Uruguay

'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020

scientific article published on 07 March 2020

A decade on: Follow-up findings of indigenous children with bronchiectasis

artículo científico publicado en 2020

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

scientific article published on 25 April 2020

A prospective randomized trial comparing supraglottic airways for flexible bronchoscopy in children.

artículo científico publicado en 2010

Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis.

artículo científico publicado en 2017

Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial

artículo científico publicado en 2018

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial

artículo científico publicado en 2012

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

scientific article published on 31 October 2019

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial

artículo científico publicado en 2012

Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial

artículo científico publicado en 2013

Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention

COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020

scientific article published on 02 December 2020

Chronic respiratory symptoms and diseases among indigenous children

artículo científico publicado en 2009

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines

artículo científico publicado en 2015

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

artículo científico publicado en 2015

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

artículo científico publicado en 2010

Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis

artículo científico publicado en 2014

Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?

artículo científico publicado en 2010

Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort

artículo científico publicado en 2020

Effect of Bronchoalveolar Lavage–Directed Therapy on Pseudomonas aeruginosa Infection and Structural Lung Injury in Children With Cystic Fibrosis ⬇️

artículo científico publicado el 13 de julio de 2011

Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial

scientific article published on 16 August 2019

Exhaled nitric oxide measurements in normal and asthmatic children

artículo científico publicado en 1997

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Tr

scientific article published in 2022

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial

artículo científico publicado en 2019

Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study

artículo científico publicado en 2019

Heated humidification improves clinical outcomes, compared to a heat and moisture exchanger in children with tracheostomies.

artículo científico publicado en 2013

Humidification difficulties in two tracheostomized children

scientific article published on 01 December 1999

Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

artículo científico publicado en 2013

Invasive multifocal cryptococcal airway disease in a teenager with hypogammaglobulinemia

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

artículo científico publicado en 2013

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

artículo científico publicado en 2015

Nebulised gentamicin-suitable for childhood bronchiectasis.

artículo científico publicado en 2005

New Zealand national incidence of bronchiectasis "too high" for a developed country.

artículo científico publicado en 2005

Nitric oxide levels and ciliary beat frequency in indigenous New Zealand children.

artículo científico publicado en 2005

Non cystic fibrosis bronchiectasis

scientific article published on 06 June 2006

Non-invasive method of measuring airway inflammation : exhaled nitric oxide ⬇️

2008 doctoral thesis by Catherine Ann Byrnes at University of Auckland

Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients

artículo científico publicado en 2007

Outcomes in children treated for persistent bacterial bronchitis

artículo científico publicado en 2007

PHARMAC and Ventolin in New Zealand.

artículo científico publicado en 2005

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

artículo científico publicado en 2003

Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia

artículo científico publicado en 2020

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

artículo científico publicado en 2013

Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis

artículo científico publicado en 2006

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis

Respiratory Health of Pacific Youth: An Observational Study of Associated Risk and Protective Factors Throughout Childhood

artículo científico publicado en 2020

Respiratory Health of Pacific Youth: An Observational Study of Associated Risk and Protective Factors Throughout Childhood (Preprint)

Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection

artículo científico publicado en 2012

Respiratory infections in Tamariki (children) and Taitamariki (young people) Māori, New Zealand

artículo científico publicado en 2010

Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.

artículo científico publicado en 2003

Safety of bronchoalveolar lavage in young children with cystic fibrosis

artículo científico publicado en 2008

Social determinants of respiratory health from birth: still of concern in the 21st century?

Surveillance of pediatric parapneumonic effusion/empyema in New Zealand

scholarly article

The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity

artículo científico publicado en 2019

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2022

The future of cystic fibrosis care: a global perspective

artículo científico publicado en 2019

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

artículo científico publicado en 2020

The perceptions and preferences of parents of children with tracheostomies in a study of humidification therapy

artículo científico publicado en 2009

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

artículo científico publicado en 2015

Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children

artículo científico publicado en 2015

Transitioning from paediatric to adult services with cystic fibrosis or bronchiectasis: What is the impact on engagement and health outcomes?

artículo científico publicado en 2020

Treatment of paediatric non-cystic fibrosis bronchiectasis

artículo científico publicado en 2004

Tuberculosis in New Zealand, 1992-2001: a resurgence

artículo científico publicado en 2005

Lista de obras de Catherine A. Byrnes

'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020

A decade on: Follow-up findings of indigenous children with bronchiectasis

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

A prospective randomized trial comparing supraglottic airways for flexible bronchoscopy in children.

Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis.

Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial

Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial

Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention

COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020

Chronic respiratory symptoms and diseases among indigenous children

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines.

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis

Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?

Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort

Effect of Bronchoalveolar Lavage–Directed Therapy on Pseudomonas aeruginosa Infection and Structural Lung Injury in Children With Cystic Fibrosis ⬇️

Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial

Exhaled nitric oxide measurements in normal and asthmatic children

Extended Versus Standard Antibiotic Course Duration in Children &lt;5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Tr

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial

Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study

Heated humidification improves clinical outcomes, compared to a heat and moisture exchanger in children with tracheostomies.

Humidification difficulties in two tracheostomized children

Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Invasive multifocal cryptococcal airway disease in a teenager with hypogammaglobulinemia

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Nebulised gentamicin-suitable for childhood bronchiectasis.

New Zealand national incidence of bronchiectasis "too high" for a developed country.

Nitric oxide levels and ciliary beat frequency in indigenous New Zealand children.

Non cystic fibrosis bronchiectasis

Non-invasive method of measuring airway inflammation : exhaled nitric oxide ⬇️

Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients

Outcomes in children treated for persistent bacterial bronchitis

PHARMAC and Ventolin in New Zealand.

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis

Respiratory Health of Pacific Youth: An Observational Study of Associated Risk and Protective Factors Throughout Childhood

Respiratory Health of Pacific Youth: An Observational Study of Associated Risk and Protective Factors Throughout Childhood (Preprint)

Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection

Respiratory infections in Tamariki (children) and Taitamariki (young people) Māori, New Zealand

Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.

Safety of bronchoalveolar lavage in young children with cystic fibrosis

Social determinants of respiratory health from birth: still of concern in the 21st century?

Surveillance of pediatric parapneumonic effusion/empyema in New Zealand

The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

The future of cystic fibrosis care: a global perspective

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

The perceptions and preferences of parents of children with tracheostomies in a study of humidification therapy

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children

Transitioning from paediatric to adult services with cystic fibrosis or bronchiectasis: What is the impact on engagement and health outcomes?

Treatment of paediatric non-cystic fibrosis bronchiectasis

Tuberculosis in New Zealand, 1992-2001: a resurgence

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Tr